Annexin A2: A Tissue Plasminogen Activator Amplifier for Thrombolytic Stroke Therapy

Stroke - United States
doi 10.1161/strokeaha.110.596106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Thrombolytic Therapy for Acute Stroke in Late Pregnancy With Intra-Arterial Recombinant Tissue Plasminogen Activator

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2005English

Successful Thrombolytic Therapy With Recombinant Tissue-Type Plasminogen Activator for Massive Pulmonary Embolism -A Case Report-

Korean Journal of Anesthesiology
AnesthesiologyPain Medicine
2010English

Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke

Expert Opinion on Drug Delivery
Pharmaceutical Science
2017English

Tissue Plasminogen Activator Therapy for the Eye

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2006English

Systemic Review : Role of Tissue Plasminogen Activator for Acute Ischemic Stroke

The Egyptian Journal of Hospital Medicine
2018English

Genome Response to Tissue Plasminogen Activator in Experimental Ischemic Stroke

BMC Genomics
BiotechnologyGenetics
2010English

Thrombolytic Therapy for Ischemic Stroke

Nevrologiya, Neiropsikhiatriya, Psikhosomatika
PsychiatryClinical PsychologyMental HealthNeurology
2013English

Thrombolytic Therapy for Acute Stroke

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy